Press Releases
CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity
CPhI Worldwide releases its beginning of year pharma market predictions for 2022 combining research from over 350 pharma executives and expert views from 10...
Press Releases
Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of COVID-19 Vaccine in 2022
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a revised supply agreement with the government of South Korea for...
Drug Research
Ascletis expands production of ritonavir oral tablets & oral direct-acting antiviral R&D pipeline to treat SARS-CoV-2 infection
Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2...
Drug Research
Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine
Amyris, Inc., a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market operating platform, and ImmunityBio, a clinical-stage immunotherapy company,...
Clinical Trials
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...
News
Pfizer and BioNTech Receive U.S. FDA EUA of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the EUA of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to...
Articles
2022 Cold Chain Predictions: Creating a new Normal
At this time last year, the world was eagerly anticipating 2021. COVID-19 vaccines delivered hope for normalcy and excitement grew over convenience-related changes to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read